Tremor and generalized mioclonus caused by meglumine antimoniate

Descripción del Articulo

Cutaneous Leishmaniasis is an endemic pathology in Peru, the first line treatment being pentavalent antimonials. Occasional antimonials as the side effect, neurological symptoms that can become incapacitating, so we must be strict in the dosage at the time of administration. We present the case of a...

Descripción completa

Detalles Bibliográficos
Autores: Torres-Ramírez, Luis, Pérez-Almedo, Melissa, Vélez-Rojas, Miriam, Flores-Mendoza, Martha, Arias-Hancco, Víctor
Formato: artículo
Fecha de Publicación:2020
Institución:Fundación Instituto Hipólito Unanue
Repositorio:Diagnóstico
Lenguaje:español
OAI Identifier:oai:revistadiagnostico.fihu.org.pe:article/207
Enlace del recurso:https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/207
Nivel de acceso:acceso abierto
Materia:Antimoniales pentavalentes
ataxia
mioclonía generalizada
temblor
Ataxia
generalized myoclonus
pentavalent antimonials
tremor
id REVFIHU_1d61ec47bca1a272d004519a4f26c5a7
oai_identifier_str oai:revistadiagnostico.fihu.org.pe:article/207
network_acronym_str REVFIHU
network_name_str Diagnóstico
repository_id_str
spelling Tremor and generalized mioclonus caused by meglumine antimoniateTemblor y mioclonías generalizadas provocadas por antimoniato de megluminaTorres-Ramírez, LuisPérez-Almedo, MelissaVélez-Rojas, MiriamFlores-Mendoza, MarthaArias-Hancco, VíctorAntimoniales pentavalentesataxiamioclonía generalizadatemblorAtaxiageneralized myoclonuspentavalent antimonialstremorCutaneous Leishmaniasis is an endemic pathology in Peru, the first line treatment being pentavalent antimonials. Occasional antimonials as the side effect, neurological symptoms that can become incapacitating, so we must be strict in the dosage at the time of administration. We present the case of a 56-year-old male patient, who treated with Meglumina Antimoniate (Glucantime®), presented tremor, dysmetria, ataxia and generalized myoclonus that prevented him from walkingLa Leishmaniasis cutánea es una patología endémica en Perú, el tratamiento de primera línea son los antimoniales pentavalentes. Los antimoniales ocasionan como efecto secundario, síntomas neurológicos que pueden llegar a ser incapacitantes, por lo que debemos ser estrictos en la dosificación al momento de administrarlos. Presentamos el caso de un paciente varón de 56 años, que luego de tratamiento con antimoniato de Meglumina (Glucantime®), presenta temblor, dismetría, ataxia y mioclonías generalizadas que le impiden la marcha.Fundación Instituto Hipólito Unanue2020-10-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/20710.33734/diagnostico.v59i1.207Diagnóstico; Vol. 59 No. 1 (2020); 35-37Diagnostico; Vol. 59 Núm. 1 (2020); 35-371018-28882709-795110.33734/diagnostico.v59i1reponame:Diagnósticoinstname:Fundación Instituto Hipólito Unanueinstacron:FIHUspahttps://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/207/211Derechos de autor 2020 Luis Torres-Ramírez, Melissa Pérez-Almedo, Miriam Vélez-Rojas, Martha Flores-Mendoza, Víctor Arias-Hanccoinfo:eu-repo/semantics/openAccessoai:revistadiagnostico.fihu.org.pe:article/2072021-06-04T18:03:19Z
dc.title.none.fl_str_mv Tremor and generalized mioclonus caused by meglumine antimoniate
Temblor y mioclonías generalizadas provocadas por antimoniato de meglumina
title Tremor and generalized mioclonus caused by meglumine antimoniate
spellingShingle Tremor and generalized mioclonus caused by meglumine antimoniate
Torres-Ramírez, Luis
Antimoniales pentavalentes
ataxia
mioclonía generalizada
temblor
Ataxia
generalized myoclonus
pentavalent antimonials
tremor
title_short Tremor and generalized mioclonus caused by meglumine antimoniate
title_full Tremor and generalized mioclonus caused by meglumine antimoniate
title_fullStr Tremor and generalized mioclonus caused by meglumine antimoniate
title_full_unstemmed Tremor and generalized mioclonus caused by meglumine antimoniate
title_sort Tremor and generalized mioclonus caused by meglumine antimoniate
dc.creator.none.fl_str_mv Torres-Ramírez, Luis
Pérez-Almedo, Melissa
Vélez-Rojas, Miriam
Flores-Mendoza, Martha
Arias-Hancco, Víctor
author Torres-Ramírez, Luis
author_facet Torres-Ramírez, Luis
Pérez-Almedo, Melissa
Vélez-Rojas, Miriam
Flores-Mendoza, Martha
Arias-Hancco, Víctor
author_role author
author2 Pérez-Almedo, Melissa
Vélez-Rojas, Miriam
Flores-Mendoza, Martha
Arias-Hancco, Víctor
author2_role author
author
author
author
dc.subject.none.fl_str_mv Antimoniales pentavalentes
ataxia
mioclonía generalizada
temblor
Ataxia
generalized myoclonus
pentavalent antimonials
tremor
topic Antimoniales pentavalentes
ataxia
mioclonía generalizada
temblor
Ataxia
generalized myoclonus
pentavalent antimonials
tremor
description Cutaneous Leishmaniasis is an endemic pathology in Peru, the first line treatment being pentavalent antimonials. Occasional antimonials as the side effect, neurological symptoms that can become incapacitating, so we must be strict in the dosage at the time of administration. We present the case of a 56-year-old male patient, who treated with Meglumina Antimoniate (Glucantime®), presented tremor, dysmetria, ataxia and generalized myoclonus that prevented him from walking
publishDate 2020
dc.date.none.fl_str_mv 2020-10-13
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/207
10.33734/diagnostico.v59i1.207
url https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/207
identifier_str_mv 10.33734/diagnostico.v59i1.207
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/207/211
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
publisher.none.fl_str_mv Fundación Instituto Hipólito Unanue
dc.source.none.fl_str_mv Diagnóstico; Vol. 59 No. 1 (2020); 35-37
Diagnostico; Vol. 59 Núm. 1 (2020); 35-37
1018-2888
2709-7951
10.33734/diagnostico.v59i1
reponame:Diagnóstico
instname:Fundación Instituto Hipólito Unanue
instacron:FIHU
instname_str Fundación Instituto Hipólito Unanue
instacron_str FIHU
institution FIHU
reponame_str Diagnóstico
collection Diagnóstico
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1843353548605095936
score 13.261195
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).